Further research has shown that, under the action of BTZ, TRIM28 enters the nucleus and activates the expression of various proteasome subunits, thereby making HCC cells resistant to BTZ (Zhang et al., 2022). This evidence concerns the gene TRIM28 and hepatocellular carcinoma.